無法觀看影音復健影片
今天進入復健影片，結果一片空白，無法觀看
巴金森寶典
Published by: William Lin
Description
【發行單位／社團法人台灣巴金森之友協會】
定時使用藥物是治療巴金森病 (Parkinson's disease) 最有效的方法，下載「巴金森寶典」，貼心提醒您準時用藥，還能輕鬆記錄用藥療效，是您和醫師溝通藥物效果的好幫手！
【醫療免責聲明】
此 App 所介紹之藥品均為醫師提供、認可之處方藥，在做出任何醫療決定之前，還應徵求醫生之意見。
定時使用藥物是治療巴金森病 (Parkinson's disease) 最有效的方法，下載「巴金森寶典」，貼心提醒您準時用藥，還能輕鬆記錄用藥療效，是您和醫師溝通藥物效果的好幫手！
【醫療免責聲明】
此 App 所介紹之藥品均為醫師提供、認可之處方藥，在做出任何醫療決定之前，還應徵求醫生之意見。
Screenshots
巴金森寶典 FAQ
-
Is 巴金森寶典 free?
Yes, 巴金森寶典 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 巴金森寶典 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 巴金森寶典 cost?
巴金森寶典 is free.
-
What is 巴金森寶典 revenue?
To get estimated revenue of 巴金森寶典 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Thailand yet.
Ratings History
巴金森寶典 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
135
|
巴金森寶典 Installs
Last 30 days
巴金森寶典 Revenue
Last 30 days巴金森寶典 Revenue and Downloads
Gain valuable insights into 巴金森寶典 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
William Lin
- Languages
- English
- Recent release
- 1.3.22 (2 months ago )
- Released on
- Apr 9, 2019 (5 years ago )
- Also available in
- Taiwan, United States, India, South Africa, Türkiye, Thailand, Singapore, Sweden, Russia, Peru, New Zealand, Norway, Nigeria, Japan, Italy, United Arab Emirates, Israel, Ireland, Indonesia, United Kingdom, France, Finland, Spain, Egypt, Denmark, China, Chile, Switzerland, Brazil, Azerbaijan
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.